App-Quantinova.ai

Validation of a Profile of 4 Plasmatic Metabolites Associated with Venous Thromboembolism

. Fernndez-Pardo - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Specific Protein Plasma Profile Associated to Venous Thromboembolism

. Fernndez-Pardo - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Serum Lipoprotein (a) Is Not Increased in Patients with Previous Spontaneous Venous Thrombosis or Correlated with Global Fibrinolysis

A. Lamnica - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Defining the Functional Role and Regulatory Mechanism of Fibrinogen Phosphorylation in Inflammation and Thrombosis

K.R. Simpson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Alkaline phosphatase

Genetic Abnormalities of Japanese Patient with Symptomatic‐ and Asymptomatic‐dysfibrinogenemia

Y. Hattori - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Methadone hydrochloride

A Chemical Screen Identifies Small Molecule Modulators of Fibrinogen Production and Experimental Venous Thrombosis

R. Vilar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Fibrinogen (IV)

Both Hemorrhagic and Thrombotic Complications in a Patient with Anti‐factor XIII Autoantibody; Characterization of the Antibody

J. Bovet - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Exploratory Study of Fibrinolytic Parameters in Patients with JAK2V617F Positive Essential Thrombocythemia

S. Phusanti - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Fibrinogen (IV)

A New Treatment for Thrombosis Prevention?

B. Dahlf - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Indications and Outcomes of Thrombolytic Therapy 2010‐2016: A Retrospective Single Center Study

M.M. Engelen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Correlating Clinical and Radiological Assessment of Joints in Hemophilia: Results of Hemophilia Study Group of Taiwan Society of Thrombosis and Hemostasis

T.-F. Weng - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Extended Half‐life Recombinant Factor IXFc Is Effective in Preventing Bleeding after Major and Minor Surgery in Severe Factor IX Deficiency

M. O'Donovan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A United States Multi‐center Analysis of Characteristics Associated with Prescribed Factor Prophylaxis

D. Tran - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Hypodysfibrinogenemia in a Patient with Aortic Valve Thrombosis and Stroke: Diagnosis and Evolution. Identification of a Novel Heterozygous Fibrinogen Gamma Chain Mutation

V. Privitera - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Fibrinogen (IV)

Poor DDAVP Response Does Not Explain Elevated Bleeding Score in Persons with Low von Willebrand Factor

M.C. Brown - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Hemostatic Solution

Von Willebrand Disease: An International Survey Assessing Important Topics for Decision‐making

M.A. Kalot - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Venous Thromboembolism Trends and Impact in Patients with Cirrhosis: Analysis of The National Inpatient Sample Database 2003‐2014

I. Greenberg - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Acquired Hemophilia A with an Exorbitant Inhibitor and Venous Thrombosis: Successfull Treatment with Recombinant Porcine FVIII Plus Recombinant FVIIa and Immediate Anti‐CD20 Therapy

M. Herma - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

FVIII

Predictive Value of Soluble Fibrin and New Diagnostic Criteria by the Japanese Society on Thrombosis and Hemostasis (JSTH) for the Prognosis of Patients with Sepsis‐associated Disseminated Intravascular Coagulation

Y. Kondoh - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Estimated Impact of New Therapies on Factor VIII (FVIII) Use and Product Cost by 2023

J. Ducore - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

FVIII

Filters

7277 Abstracts